[["index.html", "reportRmd Package 1 Overview", " reportRmd Package 1 Overview reportRmd is a package designed to facilitate the reporting of common statistical outputs easily in RMarkdown documents. The package supports pdf, html and word output without any changes to the body of the report. The main features are Table 1 style summaries, combining multiple univariate regression models into a single table, tidy multivariable model output and combining univariate and multivariable regressions into a single table. Single table summaries of median survival times and survival probabilities are also provided. A highly customisable survival curve function, based on ggplot2 can be used to create publication-quality plots. Visualisation plots are also available for bivariate relationships and logistic regression models. A word of caution: The reportRmd package is designed to facilitate statistical reporting and does not provide any checks regarding the suitability of the models fit. "],["summary-statistics.html", "2 Summary statistics", " 2 Summary statistics Basic summary statistics rm_covsum(data=pembrolizumab, covs=c(&#39;age&#39;,&#39;sex&#39;)) n=94 age Mean (sd) 57.9 (12.8) Median (Min,Max) 59.1 (21.1, 81.8) sex Female 58 (62) Male 36 (38) Set IQR = T for interquartile range instead of Min/Max rm_covsum(data=pembrolizumab, covs=c(&#39;age&#39;,&#39;sex&#39;),IQR=TRUE) n=94 age Mean (sd) 57.9 (12.8) Median (Q1,Q3) 59.1 (49.5, 68.7) sex Female 58 (62) Male 36 (38) Or all.stats=T for both rm_covsum(data=pembrolizumab, covs=c(&#39;age&#39;,&#39;sex&#39;),all.stats = TRUE) n=94 age Mean (sd) 57.9 (12.8) Median (Q1,Q3) 59.1 (49.5, 68.7) Range (min, max) (21.1, 81.8) sex Female 58 (62) Male 36 (38) "],["summaries-by-group.html", "2.1 Summaries By Group", " 2.1 Summaries By Group This will produce summary statistics by Sex rm_covsum(data=pembrolizumab, maincov = &#39;sex&#39;, covs=c(&#39;age&#39;,&#39;pdl1&#39;,&#39;change_ctdna_group&#39;)) Full Sample (n=94) Female (n=58) Male (n=36) p-value age 0.30 Mean (sd) 57.9 (12.8) 56.9 (12.6) 59.3 (13.1) Median (Min,Max) 59.1 (21.1, 81.8) 56.6 (34.1, 78.2) 61.2 (21.1, 81.8) pdl1 0.76 Mean (sd) 13.9 (29.2) 15.0 (30.5) 12.1 (27.3) Median (Min,Max) 0 (0, 100) 0.5 (0.0, 100.0) 0 (0, 100) Missing 1 0 1 change ctdna group 0.81 Decrease from baseline 33 (45) 19 (48) 14 (42) Increase from baseline 40 (55) 21 (52) 19 (58) Missing 21 18 3 "],["showing-statistical-tests.html", "2.2 Showing Statistical Tests", " 2.2 Showing Statistical Tests To indicate which statistical test was used use show.tests=TRUE rm_covsum(data=pembrolizumab, maincov = &#39;sex&#39;, covs=c(&#39;age&#39;,&#39;pdl1&#39;,&#39;change_ctdna_group&#39;), show.tests=TRUE) Full Sample (n=94) Female (n=58) Male (n=36) p-value StatTest age 0.30 Wilcoxon Rank Sum Mean (sd) 57.9 (12.8) 56.9 (12.6) 59.3 (13.1) Median (Min,Max) 59.1 (21.1, 81.8) 56.6 (34.1, 78.2) 61.2 (21.1, 81.8) pdl1 0.76 Wilcoxon Rank Sum Mean (sd) 13.9 (29.2) 15.0 (30.5) 12.1 (27.3) Median (Min,Max) 0 (0, 100) 0.5 (0.0, 100.0) 0 (0, 100) Missing 1 0 1 change ctdna group 0.81 Fisher Exact Decrease from baseline 33 (45) 19 (48) 14 (42) Increase from baseline 40 (55) 21 (52) 19 (58) Missing 21 18 3 "],["parametric-vs-non-parametric-comparisons.html", "2.3 Parametric vs Non-parametric Comparisons", " 2.3 Parametric vs Non-parametric Comparisons Group comparisons are non-parametric by default, specify testcont='ANOVA' for t-tests/ANOVA rm_covsum(data=pembrolizumab, maincov = &#39;sex&#39;, covs=c(&#39;age&#39;,&#39;pdl1&#39;), testcont=&#39;ANOVA&#39;, show.tests=TRUE) Full Sample (n=94) Female (n=58) Male (n=36) p-value StatTest age 0.39 t-test Mean (sd) 57.9 (12.8) 56.9 (12.6) 59.3 (13.1) Median (Min,Max) 59.1 (21.1, 81.8) 56.6 (34.1, 78.2) 61.2 (21.1, 81.8) pdl1 0.63 t-test Mean (sd) 13.9 (29.2) 15.0 (30.5) 12.1 (27.3) Median (Min,Max) 0 (0, 100) 0.5 (0.0, 100.0) 0 (0, 100) Missing 1 0 1 "],["row-vs-column-summaries.html", "2.4 Row vs Column Summaries", " 2.4 Row vs Column Summaries The default is to indicate percentages by columns (ie percentages within columns add to 100) rm_covsum(data=pembrolizumab, maincov = &#39;sex&#39;, covs=c(&#39;cohort&#39;), pvalue = FALSE) Full Sample (n=94) Female (n=58) Male (n=36) cohort A 16 (17) 3 (5) 13 (36) B 18 (19) 18 (31) 0 (0) C 18 (19) 18 (31) 0 (0) D 12 (13) 7 (12) 5 (14) E 30 (32) 12 (21) 18 (50) But you can also specify to show by row instead rm_covsum(data=pembrolizumab, maincov = &#39;sex&#39;, covs=c(&#39;cohort&#39;), pvalue = FALSE, percentage=&#39;row&#39;) Full Sample (n=94) Female (n=58) Male (n=36) cohort A 16 3 (19) 13 (81) B 18 18 (100) 0 (0) C 18 18 (100) 0 (0) D 12 7 (58) 5 (42) E 30 12 (40) 18 (60) "],["univariate-regression.html", "3 Univariate regression", " 3 Univariate regression Combining multiple univariate regression analyses into a single table. The function will try to determine the most appropriate model from the data. rm_uvsum(data=pembrolizumab, response=&#39;orr&#39;, covs=c(&#39;age&#39;,&#39;pdl1&#39;,&#39;change_ctdna_group&#39;)) OR(95%CI) p-value N age 0.96 (0.91, 1.00) 0.09 94 pdl1 0.97 (0.95, 0.98) &lt;0.001 93 change ctdna group 0.002 73 Decrease from baseline Reference 33 Increase from baseline 28.74 (5.20, 540.18) 40 "],["simple-linear-regression.html", "3.1 Simple Linear Regression", " 3.1 Simple Linear Regression If the response is continuous linear regression is the default. Using type = 'linear' will ensure linear regression. rm_uvsum(data=pembrolizumab, response=&#39;l_size&#39;, covs=c(&#39;age&#39;,&#39;cohort&#39;)) Estimate(95%CI) p-value Global p-value N age -0.58 (-1.54, 0.38) 0.23 94 cohort &lt;0.001 94 A Reference 16 B -38.04 (-74.95, -1.13) 0.04 18 C 20.35 (-16.56, 57.26) 0.28 18 D -24.79 (-65.82, 16.23) 0.23 12 E 31.69 (-1.56, 64.95) 0.06 30 "],["logistic-regression.html", "3.2 Logistic Regression", " 3.2 Logistic Regression If the response is binomial, logistic regression will be run (or specified with type = 'logistic'). rm_uvsum(data=pembrolizumab, response=&#39;orr&#39;, covs=c(&#39;age&#39;,&#39;cohort&#39;)) OR(95%CI) p-value Global p-value N age 0.96 (0.91, 1.00) 0.09 94 cohort &lt;0.001 94 A Reference 16 B 7.3e+07 (8.5e-76, NA) 0.99 18 C 7.3e+07 (7.7e-74, NA) 0.99 18 D 0.12 (0.02, 0.60) 0.01 12 E 1.15 (0.21, 5.49) 0.86 30 "],["poisson-regression.html", "3.3 Poisson Regression", " 3.3 Poisson Regression If the response is integer, poisson regression will be run (or specified with type = 'poisson'). pembrolizumab$Counts &lt;- rpois(nrow(pembrolizumab),lambda = 3) rm_uvsum(data=pembrolizumab, response=&#39;Counts&#39;, covs=c(&#39;age&#39;,&#39;cohort&#39;)) RR(95%CI) p-value Global p-value N age 1.00 (0.99, 1.01) 0.79 94 cohort 0.34 94 A Reference 16 B 0.76 (0.51, 1.12) 0.17 18 C 0.87 (0.60, 1.28) 0.48 18 D 0.99 (0.65, 1.48) 0.95 12 E 1.07 (0.77, 1.49) 0.70 30 "],["survival-analysis.html", "3.4 Survival Analysis", " 3.4 Survival Analysis If two response variables are specified and then survival analysis is run (specified with type='coxph'). rm_uvsum(data=pembrolizumab, response=c(&#39;os_time&#39;,&#39;os_status&#39;), covs=c(&#39;age&#39;,&#39;pdl1&#39;,&#39;change_ctdna_group&#39;)) HR(95%CI) p-value N age 0.99 (0.97, 1.01) 0.16 94 pdl1 0.99 (0.98, 1.00) 0.03 93 change ctdna group &lt;0.001 73 Decrease from baseline Reference 33 Increase from baseline 3.06 (1.62, 5.77) 40 "],["competing-risk.html", "3.5 Competing Risk", " 3.5 Competing Risk Competing risk models need to be explicitly specified using type='crr'. rm_uvsum(data=pembrolizumab, response=c(&#39;os_time&#39;,&#39;os_status&#39;), covs=c(&#39;age&#39;,&#39;pdl1&#39;,&#39;change_ctdna_group&#39;), type=&#39;crr&#39;) HR(95%CI) p-value N age 0.99 (0.97, 1.00) 0.15 94 pdl1 0.99 (0.98, 1.00) 0.02 93 change ctdna group &lt;0.001 73 Decrease from baseline Reference 33 Increase from baseline 3.06 (1.64, 5.69) 40 "],["gee-models.html", "3.6 GEE Models", " 3.6 GEE Models Correlated observations can be handled using GEE rm_uvsum(response = &#39;size_change&#39;, covs=c(&#39;time&#39;,&#39;ctdna_status&#39;), gee=TRUE, id=&#39;id&#39;, corstr=&quot;exchangeable&quot;, family=gaussian(&quot;identity&quot;), data=ctDNA,showN=TRUE) Estimate(95%CI) p-value Global p-value N time -0.12 (-0.44, 0.19) 0.44 262 ctdna status &lt;0.001 262 Clearance Reference 134 No clearance, decrease from baseline 61.29 (37.38, 85.20) &lt;0.001 42 No clearance, increase from baseline 82.52 (64.67, 100.37) &lt;0.001 86 "],["returning-model-objects.html", "3.7 Returning Model Objects", " 3.7 Returning Model Objects If you want to check the underlying models, set returnModels = TRUE rm_uvsum(response = &#39;orr&#39;, covs=c(&#39;age&#39;), data=pembrolizumab,returnModels = TRUE) ## $age ## ## Call: glm(formula = orr ~ age, family = binomial, data = data) ## ## Coefficients: ## (Intercept) age ## 4.12269 -0.04231 ## ## Degrees of Freedom: 93 Total (i.e. Null); 92 Residual ## Null Deviance: 85.77 ## Residual Deviance: 82.53 AIC: 86.53 The data analysed can be examined by interrogating the data object appended to each model mList &lt;- rm_uvsum(response = &#39;orr&#39;, covs=c(&#39;age&#39;), data=pembrolizumab,returnModels = TRUE) head(mList$age$data) ## # A tibble: 6 Ã— 2 ## orr age ## &lt;fct&gt; &lt;dbl&gt; ## 1 SD/PD 62.1 ## 2 SD/PD 62.2 ## 3 CR/PR 70.9 ## 4 SD/PD 57.9 ## 5 SD/PD 65.7 ## 6 SD/PD 60.9 "],["adjusting-p-values.html", "3.8 Adjusting p-values", " 3.8 Adjusting p-values Multiple comparisons can be controlled for with the p.adjust argument, which accepts any of the options from the p.adjust function. rm_uvsum(response = &#39;orr&#39;, covs=c(&#39;age&#39;,&#39;sex&#39;,&#39;pdl1&#39;), data=pembrolizumab,p.adjust = &#39;fdr&#39;) OR(95%CI) p-value N raw p-value age 0.96 (0.91, 1.00) 0.11 94 0.09 sex 0.11 94 0.11 Female Reference 58 Male 0.41 (0.13, 1.22) 36 pdl1 0.97 (0.95, 0.98) &lt;0.001 93 &lt;0.001 Note: The raw p-value column is suppressed when there are categorical variables with &gt;2 levels, to prevent three columns of p-values from appearing. "],["multivariable-analysis.html", "4 Multivariable analysis", " 4 Multivariable analysis To create a nice display for multivariable models the multivariable model first needs to be fit. By default, the variance inflation factor will be shown to check for multicollinearity. To suppress this column set vif=FALSE. Note: variance inflation factors are not computed (yet) for multilevel or GEE models. glm_fit &lt;- glm(orr~change_ctdna_group+pdl1+age, family=&#39;binomial&#39;, data = pembrolizumab) rm_mvsum(glm_fit, showN = TRUE, vif=TRUE) OR(95%CI) p-value N VIF change ctdna group 0.006 73 1.03 Decrease from baseline Reference 33 Increase from baseline 23.92 (2.49, 229.77) 40 pdl1 0.97 (0.95, 0.99) 0.01 73 1.24 age 0.94 (0.87, 1.01) 0.08 73 1.23 "],["combining-univariate-and-multivariable-models.html", "5 Combining univariate and multivariable models", " 5 Combining univariate and multivariable models To display both models in a single table run the rm_uvsum and rm_mvsum functions with tableOnly=TRUE and combine. uvsumTable &lt;- rm_uvsum(data=pembrolizumab, response=&#39;orr&#39;, covs=c(&#39;age&#39;,&#39;sex&#39;,&#39;pdl1&#39;,&#39;change_ctdna_group&#39;),tableOnly = TRUE) glm_fit &lt;- glm(orr~change_ctdna_group+pdl1, family=&#39;binomial&#39;, data = pembrolizumab) mvsumTable &lt;- rm_mvsum(glm_fit, showN = TRUE,tableOnly = TRUE) rm_uv_mv(uvsumTable,mvsumTable) Unadjusted OR(95%CI) N p Adjusted OR(95%CI) N (adj) p (adj) age 0.96 (0.91, 1.00) 94 0.09 sex 94 0.11 Female Reference 58 Male 0.41 (0.13, 1.22) 36 pdl1 0.97 (0.95, 0.98) 93 &lt;0.001 0.98 (0.96, 1.00) 73 0.02 change ctdna group 73 0.002 73 0.004 Decrease from baseline Reference 33 Reference 33 Increase from baseline 28.74 (5.20, 540.18) 40 24.71 (2.87, 212.70) 40 Note: This can also be done with adjusted p-values, but when combined the raw p-values are dropped. "],["changing-the-output.html", "6 Changing the output", " 6 Changing the output If you need to make changes to the tables, setting tableOnly=TRUE will return a data frame for any of the rm_ functions. Changes can be made, and the table output using outTable() mvsumTable &lt;- rm_mvsum(glm_fit, showN = TRUE,tableOnly = TRUE) names(mvsumTable)[1] &lt;-&#39;Predictor&#39; outTable(mvsumTable) Predictor OR(95%CI) p-value N VIF change ctdna group 0.004 73 1.01 Decrease from baseline Reference 33 Increase from baseline 24.71 (2.87, 212.70) 40 pdl1 0.98 (0.96, 1.00) 0.02 73 1.01 "],["combining-tables.html", "7 Combining tables", " 7 Combining tables Tables can be nested with the nestTable() function cohortA &lt;- rm_uvsum(data=subset(pembrolizumab,cohort==&#39;A&#39;), response = &#39;pdl1&#39;, covs=c(&#39;age&#39;,&#39;sex&#39;), tableOnly = T) cohortA$Cohort &lt;- &#39;Cohort A&#39; cohortE &lt;- rm_uvsum(data=subset(pembrolizumab,cohort==&#39;E&#39;), response = &#39;pdl1&#39;, covs=c(&#39;age&#39;,&#39;sex&#39;), tableOnly = T) cohortE$Cohort &lt;- &#39;Cohort E&#39; nestTable(rbind(cohortA,cohortE),head_col = &#39;Cohort&#39;,to_col = &#39;Covariate&#39;) Estimate(95%CI) p-value N Cohort A age 2.94 (-0.70, 6.58) 0.10 15 sex 0.14 15 Female Reference 3 Male -40.25 (-96.25, 15.75) 12 Cohort E age -0.44 (-1.02, 0.15) 0.14 30 sex 0.10 30 Female Reference 12 Male -14.86 (-32.57, 2.85) 18 "],["simple-survival-summaries.html", "8 Simple Survival Summaries", " 8 Simple Survival Summaries Displaying survival probabilities at different times by sex using Kaplan Meier estimates rm_survsum(data=pembrolizumab,time=&#39;os_time&#39;,status=&#39;os_status&#39;, group=&quot;sex&quot;,survtimes=seq(12,36,12),survtimeunit=&#39;months&#39;) sex Events/Total Median (95%CI) 12months (95% CI) 24months (95% CI) 36months (95% CI) Female 39/58 14.29 (9.69, 23.82) 0.55 (0.44, 0.69) 0.34 (0.24, 0.50) 0.29 (0.18, 0.45) Male 25/36 11.24 (6.14, 25.33) 0.50 (0.36, 0.69) 0.31 (0.18, 0.52) 0.27 (0.15, 0.48) Log Rank Test ChiSq 0.5 on 1 df p-value 0.46 "],["survival-times-in-long-format.html", "9 Survival Times in Long Format", " 9 Survival Times in Long Format Displaying survival probabilities at different times by sex using Cox PH estimates rm_survtime(data=pembrolizumab,time=&#39;os_time&#39;,status=&#39;os_status&#39;, strata=&quot;sex&quot;,survtimes=c(12,24),survtimeunit=&#39;mo&#39;,type=&#39;PH&#39;) Time (mo) At Risk Events Censored Survival Rate (95% CI) Overall 94 12 48 44 2 0.53 (0.44, 0.64) 24 24 17 7 0.33 (0.25, 0.45) Female 58 12 31 26 1 0.55 (0.44, 0.70) 24 16 11 4 0.35 (0.24, 0.50) Male 36 12 17 18 1 0.51 (0.37, 0.70) 24 8 6 3 0.32 (0.19, 0.52) "],["survival-times-with-covariate-adjustments.html", "9.1 Survival Times With Covariate Adjustments", " 9.1 Survival Times With Covariate Adjustments Displaying survival probabilities at different times by sex, adjusting for age using Cox PH estimates rm_survtime(data=pembrolizumab,time=&#39;os_time&#39;,status=&#39;os_status&#39;, covs=&#39;age&#39;, strata=&quot;sex&quot;,survtimes=c(12,24),survtimeunit=&#39;mo&#39;,type=&#39;PH&#39;) Time (mo) At Risk Events Censored Survival Rate (95% CI) Overall 94 12 48 44 2 0.54 (0.44, 0.65) 24 24 17 7 0.33 (0.25, 0.45) Female 58 12 31 26 1 0.56 (0.44, 0.70) 24 16 11 4 0.35 (0.24, 0.50) Male 36 12 17 18 1 0.51 (0.37, 0.70) 24 8 6 3 0.31 (0.19, 0.53) "],["stratified-survival-summary.html", "10 Stratified Survival Summary", " 10 Stratified Survival Summary To combine estimates across strata rm_survdiff(data=pembrolizumab,time=&#39;os_time&#39;,status=&#39;os_status&#39;, covs=&#39;sex&#39;,strata=&#39;cohort&#39;,digits=1) group N Observed Expected Median (95%CI) Overall 94 64 14.0 (9.0, 20.1) Female 58 39 43.0 14.3 (9.7, 23.8) Male 36 25 21.0 11.2 (6.1, 25.3) Log Rank Test ChiSq = 1.9 on 1 df stratified by cohort p-value = 0.17 "],["plotting-functions.html", "11 Plotting Functions", " 11 Plotting Functions "],["plotting-bivariate-relationships.html", "11.1 Plotting bivariate relationships", " 11.1 Plotting bivariate relationships These plots are designed for quick inspection of many variables, not for publication. This is the plotting version of rm_uvsum plotuv(data=pembrolizumab, response=&#39;orr&#39;, covs=c(&#39;age&#39;,&#39;cohort&#39;,&#39;pdl1&#39;,&#39;change_ctdna_group&#39;)) "],["plotting-odds-ratios.html", "11.2 Plotting odds ratios", " 11.2 Plotting odds ratios This will default to a log scale, but can be set to linear using logscale=FALSE require(ggplot2) glm_fit &lt;- glm(orr~age+sex+change_ctdna_group+pdl1, family=&#39;binomial&#39;, data = pembrolizumab) forestplot2(glm_fit) "],["plotting-survival-curves.html", "11.3 Plotting survival curves", " 11.3 Plotting survival curves ggkmcif(response = c(&#39;os_time&#39;,&#39;os_status&#39;), cov=&#39;cohort&#39;, data=pembrolizumab) "],["pdf-output.html", "12 PDF Output", " 12 PDF Output For pdf to be correctly generate when using survival curves it is recommended that the cairo format be used. This can be specified with the following command in the setup code chunk: knitr::opts_chunk$set(message = FALSE, warning = FALSE,dev=\"cairo_pdf\") "],["data-sets.html", "13 Data Sets", " 13 Data Sets 13.0.1 pembrolizumab Survival status and ctDNA levels for patients receiving pembrolizumab A data frame with 94 rows and 15 variables: id Patient ID age Age at study entry sex Patient Sex cohort Study Cohort: A = Squamous cell carcinoma of soft pallate, B = Triple negative breast cancer, C = Ovarian, high grade serous, D = Melanoma, E = Other Solid Tumor l_size Target lesion size at baseline pdl1 PD L1 percent tmb log of TMB baseline_ctdna Baseline ctDNA change_ctdna_group Did ctDNA increase or decrease from baseline to cycle 3 orr Objective Response cbr Clinical Beneficial Response os_status Overall survival status, 0 = alive, 1 = deceased os_time Overall survival time in months pfs_status Progression free survival status, 0 = progression free, 1 = progressed pfs_time Progression free survival time in months 13.0.2 ctDNA Longitudinal changes in tumour size since baseline for patients by changes in ctDNA status (clearance, decrease or increase) since baseline. A data frame with 270 rows and 5 variables: id Patient ID cohort Study Cohort: A = Squamous cell carcinoma of soft pallate, B = Triple negative breast cancer, C = Ovarian, high grade serous, D = Melanoma, E = Other Solid Tumor ctdna_status Change in ctDNA since baseline time Number of weeks on treatment size_change Percentage change in tumour measurement "],["404.html", "Page not found", " Page not found The page you requested cannot be found (perhaps it was moved or renamed). You may want to try searching to find the page's new location, or use the table of contents to find the page you are looking for. "]]
